ARTICLE | Distillery Therapeutics
Cancer
November 1, 2016 7:00 AM UTC
Patient sample and mouse studies suggest promoting ID2 expression or inhibiting TCF4 could help treat PGC-1α-deficient metastatic melanoma. In primary tumor samples from 68 melanoma patients, invasive...
BCIQ Company Profiles